These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2667102)

  • 1. Ciprofloxacin in meningococcal carriers.
    Visakorpi R
    Scand J Infect Dis Suppl; 1989; 60():108-11. PubMed ID: 2667102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the sanative action of rifampicin on the meningococcal carrier state].
    Deviatkina NP; Demina AA; Orlova EV; Timina VP; Petrova IS
    Antibiotiki; 1978 Sep; 23(9):794-7. PubMed ID: 100048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis.
    Gaunt PN; Lambert BE
    J Antimicrob Chemother; 1988 Apr; 21(4):489-96. PubMed ID: 3132442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin].
    González de Aledo Linos A; García Merino J
    An Esp Pediatr; 2000 Nov; 53(5):412-7. PubMed ID: 11521657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal carrier rate before and after hajj pilgrimage: effect of single dose ciprofloxacin on carriage.
    Alborzi A; Oskoee S; Pourabbas B; Alborzi S; Astaneh B; Gooya MM; Kaviani MJ
    East Mediterr Health J; 2008; 14(2):277-82. PubMed ID: 18561718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Healthy meningococcal carriers in 1973 in Greece. Sensitivity of the isolated strains to minocycline, rifampicin and sulphadiazine (author's transl)].
    Vassiliadis P; Patéraki E; Kalapothaki V; Trichopoulos D; Constantinidis E; Papadakis J
    Zentralbl Bakteriol Orig A; 1975; 230(2):159-71. PubMed ID: 807053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections.
    Schwartz B
    Rev Infect Dis; 1991; 13 Suppl 2():S170-3. PubMed ID: 2017647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of secondary cases of invasive meningococcal infection: role of chemoprophylaxis and vaccination].
    Chuard C; Regamey C
    Rev Med Suisse Romande; 2003 Mar; 123(3):151-4. PubMed ID: 15095699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease.
    Memish ZA; Alrajhi AA
    Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rifampin in treatment of meningococcal carriers.
    Deal WB; Sanders E
    N Engl J Med; 1969 Sep; 281(12):641-5. PubMed ID: 4980025
    [No Abstract]   [Full Text] [Related]  

  • 13. Ciprofloxacin vs ceftriaxone for eradication of meningococcal carriage.
    Gaunt PN
    Lancet; 1988 Jul; 2(8604):218-9. PubMed ID: 2899687
    [No Abstract]   [Full Text] [Related]  

  • 14. The problem of sulfadiazine-resistant meningococci.
    Leedom JM; Ivler D; Mathies AW; Thrupp LD; Fremont JC; Wehrle PF; Portnoy B
    Antimicrob Agents Chemother (Bethesda); 1966; 6():281-92. PubMed ID: 5985253
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin].
    Rodríguez Núñez A; Martinón Torres F; Martinón Sánchez J
    An Esp Pediatr; 2001 May; 54(5):525-6. PubMed ID: 11333489
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children].
    Faye A; Mariani-Kurkjian P; Taha MK; Louzeau C; Bingen E; Bourrillon A
    Arch Pediatr; 2005 Mar; 12(3):291-4. PubMed ID: 15734127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.